Peterborough, Canada Clinical Trials

A listing of Peterborough, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 13 clinical trials
An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects

This study is being conducted to evaluate the safety and efficacy of ALZ-801 in Early Alzheimer's disease (AD) subjects with the APOE4/4 genotype. This is a double-blind, randomized trial with one dose of ALZ-801 compared to placebo.

Kawartha Centre
 (0.2 away) Contact site
  • 0 views
  • 24 Jul, 2021
  • +67 other locations
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)

The purpose of this study is to evaluate the long-term safety and maintenance of efficacy of mirikizumab in participants with moderate-to-severe plaque psoriasis.

plaque psoriasis
mirikizumab
SKiN Centre for Dermatology
 (1.9 away) Contact site
  • 717 views
  • 25 Jul, 2021
  • +354 other locations
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.

florbetapir
positron emission tomography
alzheimer's disease
flortaucipir
mini-mental state examination
Kawartha Regional Memory Clinic
 (0.2 away) Contact site
  • 79 views
  • 24 Jul, 2021
  • +389 other locations
A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease

A phase 2 randomized, double blind, placebo controlled study evaluating the efficacy and safety of AL002 in participants with Early Alzheimer's Disease.

mini-mental state examination
amyloidosis
alzheimer's disease
Kawartha Regional Memory Clinic
 (0.2 away) Contact site
  • 0 views
  • 25 Jul, 2021
  • +85 other locations
A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease

The primary purpose of this study is to evaluate the effect of JNJ-63733657 versus placebo on cognitive decline using the Alzheimer's Disease Assessment Scale Cognitive subscale 13-item version (ADAS-Cog13).

cognitive decline
dementia
alzheimer's disease
cognitive assessment
Kawartha Centre - Redefining Healthy Aging
 (0.2 away) Contact site
  • 0 views
  • 25 Jul, 2021
  • +144 other locations
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity

The researchers are doing the study to see if semaglutide may reduce the risk of having cardiovascular events in patients with overweight or obesity and with prior cardiovascular disease. The participant will either get semaglutide (active medicine) or placebo ("dummy" medicine). Which treatment the participants get is decided by chance. …

cardiovascular disease
overweight or obesity
body mass index
Novo Nordisk Investigational Site
 (0.6 away) Contact site
  • 7712 views
  • 18 Jul, 2021
  • +1164 other locations
Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

This is a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CSL112 on reducing the risk of major adverse CV events [MACE - cardiovascular (CV) death, myocardial infarction (MI), and stroke] in subjects with acute coronary syndrome (ACS) diagnosed with either ST-segment elevation …

stemi
infarct
acute coronary syndrome
percutaneous coronary intervention
myocardial infarction
1240078 - Kawartha Cardiology Clinical Trials
 (0.6 away) Contact site
  • 1118 views
  • 25 Jul, 2021
  • +3430 other locations
A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation

This is a randomized, double-blind, placebo-controlled study in patients with dilated cardiomyopathy (DCM) due to a mutation of the gene encoding the lamin A/C protein (LMNA). The study will further evaluate a dose level of study drug (ARRY-371797) that has shown preliminary efficacy and safety in this patient population. After …

implantable cardioverter defibrillator
walk test
dilated cardiomyopathy
c protein
cardiac resynchronization therapy
Array Investigative Site
 (0.0 away) Contact site
  • 413 views
  • 25 Jul, 2021
  • +261 other locations
Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa

The purpose of this extension study is to evaluate maintenance of HiSCR response at Week 104 in either continuous or interrupted therapy (using a randomized withdrawal period) of two dose regimens and to assess long-term efficacy, safety and tolerability of secukinumab in subjects with moderate to severe hidradenitis suppurativa completing …

hidradenitis
expanded access trial
secukinumab
Novartis Investigative Site
 (1.9 away) Contact site
  • 45 views
  • 20 Jul, 2021
  • +169 other locations
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

hemoglobin a1c
cardiovascular disease
body mass index
Kawartha Cardiology Clinical Trials
 (0.6 away) Contact site
  • 593 views
  • 25 Jul, 2021
  • +888 other locations